Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2017
Immunotherapy of Prostate Cancer: Facts and HopesMarijo Bilusic, Ravi A Madan, James L Gulley
Clinical Case Reports|September 21, 2016
Solitary extraosseous plasmacytomaHussein Merza, Raj Sarkar
Human Vaccines & Immunotherapeutics|March 24, 2025
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapyChinmay T Jani, Aysswarya Manoharan, Peter J DeMaria, et al.
Cancers|November 12, 2013
Therapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of responseJoseph W Kim, Marijo Bilusic, Christopher J Heery, et al.
The Canadian Journal of Urology|April 21, 2015
Loss of e-cadherin and retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasisScott M Norberg, Michelle Oros, Varsha Manucha, et al.
Seminars in Oncology|May 19, 2012
Clinical evaluation of TRICOM vector therapeutic cancer vaccinesRavi A Madan, Marijo Bilusic, Christopher Heery, et al.
Human Vaccines & Immunotherapeutics|September 1, 2017
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinationsMargaret E Gatti-Mays, Jason M Redman, Julie M Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Recurrent bulbar paralysis caused by botulinum toxin type BMarijo Bilusic, Jean Pattathil, Michael Brescia, et al.
Clinical Case Reports|October 29, 2015
Idiopathic hyperzincemia with associated copper deficiency anemia: a diagnostic dilemmaHussein Merza, Neha Sood, Raman Sood
Urologic Oncology|November 7, 2017
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysisItalia Grenga, Renee N Donahue, Morgan L Gargulak, et al.
Pageof 7